SCHEMBL311700

SCHEMBL311700

CCOC(=O)Nc1cc(O)c(O)cc1-c1cc(=O)c2ccc(O)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
AKR1B1 P15121 1/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
GLA P06280 1/20 0.38
LMNA P02545 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312241 0.91 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL313232 0.88 HPGD (0.46) ALDH1A1MEN1KMT2AHSD17B10SMN1; SMN2
SCHEMBL312303 0.87 TUBB4A (0.40) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312803 0.85 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL311994 0.85 KMT2A (0.46) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL312964 0.84 MEN1 (0.45) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL10215441 0.83 KDM4E (0.45) ALDH1A1MEN1KMT2AHSD17B10SMN1; SMN2
SCHEMBL311883 0.83 GAA (0.46) ALDH1A1MEN1KMT2AHSD17B10CYP1A2
SCHEMBL311421 0.81 MEN1 (0.42) ALDH1A1MEN1KMT2AHSD17B10ALOX15
SCHEMBL313026 0.81 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed